Ogilvy Faces Anti-Drug Challenge in Senate

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

WASHINGTON, D.C. Ogilvy & Mather’s contract for the White House’s anti-drug media campaign would be terminated and the Partnership for a Drug-Free America given an equal say in formulating ad strategy, according to language in a draft Senate bill reauthorizing the $150 million effort. That bill is expected to be introduced this week.

The measure, to be sponsored by Senators Joseph Biden (D-Del.); Charles Grassley (R-Iowa); and Orrin Hatch (R-Utah), calls for terminating Ogilvy’s contract within 90 days of the bill’s passage or exercising an option not to renew the contract.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in